Prophylaxis or treatment of experimental brucellosis with interleukin-1

Y. F. Zhan, E. R. Stanley, C. Cheers

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Intravenously injected recombinant human interleukin-1 alpha (IL-1α) given to mice 4 h before infection with Brucella abortus 19 depressed the growth of bacteria in the spleen and liver. However, the same dose (105 U) or a 10-fold higher dose was not able to decrease numbers of bacteria when given to chronically infected mice. IL-1 injected into normal mice induced a dramatic increase 2 h later in colony-stimulating activity in serum, measured by bone marrow proliferation, and in colony-stimulating factor 1, measured by radioimmunoassay. Colony-stimulating factor levels declined but remained higher than normal for at least 12 h. The early peak stimulation was not observed in chronically infected mice, but the more prolonged elevation was. As a result of IL-1 treatment, the number of colony-forming cells, especially in the spleen, was increased in normal and acutely or chronically infected mice. Myeloperoxidase staining of newly formed monocytes and polymorphonuclear cells in the spleen revealed an increase in the number of these cells in normal and acutely infected mice as a result of IL-1 treatment, but there was no increase in the already high numbers in chronically infected mice. The relationship between these observations and the basis of chronic infection are discussed.

Original languageEnglish (US)
Pages (from-to)1790-1794
Number of pages5
JournalInfection and Immunity
Volume59
Issue number5
StatePublished - 1991
Externally publishedYes

Fingerprint

Brucellosis
Interleukin-1
Interleukin-1alpha
Spleen
Bacteria
Brucella abortus
Colony-Stimulating Factors
Macrophage Colony-Stimulating Factor
Infection
Peroxidase
Radioimmunoassay
Monocytes
Cell Count
Bone Marrow
Staining and Labeling
Liver
Growth
Serum

ASJC Scopus subject areas

  • Immunology

Cite this

Zhan, Y. F., Stanley, E. R., & Cheers, C. (1991). Prophylaxis or treatment of experimental brucellosis with interleukin-1. Infection and Immunity, 59(5), 1790-1794.

Prophylaxis or treatment of experimental brucellosis with interleukin-1. / Zhan, Y. F.; Stanley, E. R.; Cheers, C.

In: Infection and Immunity, Vol. 59, No. 5, 1991, p. 1790-1794.

Research output: Contribution to journalArticle

Zhan, YF, Stanley, ER & Cheers, C 1991, 'Prophylaxis or treatment of experimental brucellosis with interleukin-1', Infection and Immunity, vol. 59, no. 5, pp. 1790-1794.
Zhan, Y. F. ; Stanley, E. R. ; Cheers, C. / Prophylaxis or treatment of experimental brucellosis with interleukin-1. In: Infection and Immunity. 1991 ; Vol. 59, No. 5. pp. 1790-1794.
@article{538927ed54e54463a2817b23ca25bb61,
title = "Prophylaxis or treatment of experimental brucellosis with interleukin-1",
abstract = "Intravenously injected recombinant human interleukin-1 alpha (IL-1α) given to mice 4 h before infection with Brucella abortus 19 depressed the growth of bacteria in the spleen and liver. However, the same dose (105 U) or a 10-fold higher dose was not able to decrease numbers of bacteria when given to chronically infected mice. IL-1 injected into normal mice induced a dramatic increase 2 h later in colony-stimulating activity in serum, measured by bone marrow proliferation, and in colony-stimulating factor 1, measured by radioimmunoassay. Colony-stimulating factor levels declined but remained higher than normal for at least 12 h. The early peak stimulation was not observed in chronically infected mice, but the more prolonged elevation was. As a result of IL-1 treatment, the number of colony-forming cells, especially in the spleen, was increased in normal and acutely or chronically infected mice. Myeloperoxidase staining of newly formed monocytes and polymorphonuclear cells in the spleen revealed an increase in the number of these cells in normal and acutely infected mice as a result of IL-1 treatment, but there was no increase in the already high numbers in chronically infected mice. The relationship between these observations and the basis of chronic infection are discussed.",
author = "Zhan, {Y. F.} and Stanley, {E. R.} and C. Cheers",
year = "1991",
language = "English (US)",
volume = "59",
pages = "1790--1794",
journal = "Infection and Immunity",
issn = "0019-9567",
publisher = "American Society for Microbiology",
number = "5",

}

TY - JOUR

T1 - Prophylaxis or treatment of experimental brucellosis with interleukin-1

AU - Zhan, Y. F.

AU - Stanley, E. R.

AU - Cheers, C.

PY - 1991

Y1 - 1991

N2 - Intravenously injected recombinant human interleukin-1 alpha (IL-1α) given to mice 4 h before infection with Brucella abortus 19 depressed the growth of bacteria in the spleen and liver. However, the same dose (105 U) or a 10-fold higher dose was not able to decrease numbers of bacteria when given to chronically infected mice. IL-1 injected into normal mice induced a dramatic increase 2 h later in colony-stimulating activity in serum, measured by bone marrow proliferation, and in colony-stimulating factor 1, measured by radioimmunoassay. Colony-stimulating factor levels declined but remained higher than normal for at least 12 h. The early peak stimulation was not observed in chronically infected mice, but the more prolonged elevation was. As a result of IL-1 treatment, the number of colony-forming cells, especially in the spleen, was increased in normal and acutely or chronically infected mice. Myeloperoxidase staining of newly formed monocytes and polymorphonuclear cells in the spleen revealed an increase in the number of these cells in normal and acutely infected mice as a result of IL-1 treatment, but there was no increase in the already high numbers in chronically infected mice. The relationship between these observations and the basis of chronic infection are discussed.

AB - Intravenously injected recombinant human interleukin-1 alpha (IL-1α) given to mice 4 h before infection with Brucella abortus 19 depressed the growth of bacteria in the spleen and liver. However, the same dose (105 U) or a 10-fold higher dose was not able to decrease numbers of bacteria when given to chronically infected mice. IL-1 injected into normal mice induced a dramatic increase 2 h later in colony-stimulating activity in serum, measured by bone marrow proliferation, and in colony-stimulating factor 1, measured by radioimmunoassay. Colony-stimulating factor levels declined but remained higher than normal for at least 12 h. The early peak stimulation was not observed in chronically infected mice, but the more prolonged elevation was. As a result of IL-1 treatment, the number of colony-forming cells, especially in the spleen, was increased in normal and acutely or chronically infected mice. Myeloperoxidase staining of newly formed monocytes and polymorphonuclear cells in the spleen revealed an increase in the number of these cells in normal and acutely infected mice as a result of IL-1 treatment, but there was no increase in the already high numbers in chronically infected mice. The relationship between these observations and the basis of chronic infection are discussed.

UR - http://www.scopus.com/inward/record.url?scp=0025756042&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025756042&partnerID=8YFLogxK

M3 - Article

VL - 59

SP - 1790

EP - 1794

JO - Infection and Immunity

JF - Infection and Immunity

SN - 0019-9567

IS - 5

ER -